Table 3.
Final classification of treatments, based on network meta-analysis of treatments for childhood diarrhea.
| Certainty of the evidence, and classification of interventiona | Category | Treatments | Treatments vs. the reference treatments (Relative risk/95% credible interval) | Surface under the cumulative ranking curve |
|---|---|---|---|---|
| High certainty (moderate to high certainty evidence) | Category 1 | CMBBA | 1.14 (1.06, 1.23) | 0.68 |
| CMBBA + MP | 1.2 (1.08, 1.33) | 0.86 | ||
| CMBBA + MP | 1.13 (1.08, 1.21) | 0.68 | ||
| CMBBA + MP + M | 1.13 (1.08, 1.21) | 0.68 | ||
| CMBBA + MP + AI | 1.23 (1.01, 1.48) | 0.88 | ||
| Category 0 | – | |||
| Low certainty (low to very low certainty evidence) | Category 1 | – | ||
| Category 0 | MP | 1.02 (0.93, 1.12) | 0.32 | |
| MP + AI | 1.02 (0.85, 1.2) | 0.31 | ||
| MP + M + AI | 0.9 (0.8, 1.02) | 0.02 |
a
Certainty of the evidence was determined based on Supplementary CINeMA results. CMBBA, Chinese medicine belly button application; MP, montmorillonite powder; M, microecologics; AI, anti-infectives.